Clinical Trials Browser

Phase 2/3 × Inflammation × Etanercept × Clear all

NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

Phase 2/3 Completed

Inflammation, Metabolic Syndrome